Suppr超能文献

咪康唑氯倍他索凝胶的建模、配方优化及质量评估

Modeling, the Optimization of the Composition of Emulgels with Ciclopirox Olamine, and Quality Assessment.

作者信息

Mazurkeviciute Agne, Matulyte Inga, Ivaskiene Marija, Zilius Modestas

机构信息

Institute of Pharmaceutical Technologies, Lithuanian University of Health Sciences, 50162 Kaunas, Lithuania.

Department of Clinical Pharmacy, Lithuanian University of Health Sciences, 50162 Kaunas, Lithuania.

出版信息

Polymers (Basel). 2024 Jun 26;16(13):1816. doi: 10.3390/polym16131816.

Abstract

The design and development of pharmaceutical products require specific knowledge, time, and investment. Response surface methodology (RSM) is a widely used technique in the design of experiments (DoE) to optimize various processes and products. The aim of this study was to model and produce experimental emulgels containing 1% ciclopirox olamine and to evaluate their physical, rheological, and mechanical properties and their ability to release ciclopirox olamine. The objective was to optimize the composition of the experimental emulgel containing 1% ciclopirox olamine by applying a central composite design based on selected criteria. The surfactant (polysorbate 80) had the greatest influence on the physical, rheological, and mechanical properties of the emulgels, as well as on the release of ciclopirox olamine from these systems. During the optimization process, an emulgel of optimal composition was generated containing 38.27% mineral oil, 6.56% polysorbate 80, and 55.17% hydrogel containing 1% ciclopirox olamine, meeting specified criteria (dependent variables) including the maximum flux of ciclopirox olamine, the minimum sol-gel transition temperature (T), and the minimum particle size of the oil phase. The oil phase particle size (D50) of this emulgel was determined to be 0.337 µm, the system T was 9.1 °C, and the flux of ciclopirox olamine from this gel matrix was calculated to be 1.44 mg/cm. This emulgel of optimal composition could be used to treat fungal skin diseases.

摘要

药品的设计与开发需要特定的知识、时间和投资。响应面法(RSM)是实验设计(DoE)中广泛使用的一种技术,用于优化各种工艺和产品。本研究的目的是对含1%环吡酮胺的实验性乳凝胶进行建模并制备,评估其物理、流变学和力学性能以及释放环吡酮胺的能力。目标是通过基于选定标准应用中心复合设计来优化含1%环吡酮胺的实验性乳凝胶的组成。表面活性剂(聚山梨酯80)对乳凝胶的物理、流变学和力学性能以及环吡酮胺从这些体系中的释放影响最大。在优化过程中,生成了一种最佳组成的乳凝胶,其含有38.27%的矿物油、6.56%的聚山梨酯80和55.17%的含1%环吡酮胺的水凝胶,满足指定标准(因变量),包括环吡酮胺的最大通量、最低溶胶-凝胶转变温度(T)和油相的最小粒径。该乳凝胶的油相粒径(D50)测定为0.337 µm,体系T为9.1℃,环吡酮胺从该凝胶基质中的通量经计算为1.44 mg/cm。这种最佳组成的乳凝胶可用于治疗真菌性皮肤病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e3/11244097/0d1b87341d21/polymers-16-01816-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验